| Literature DB >> 31637260 |
Abstract
Embryology of normal web space creation and the genetics of syndactyly in humans and experimental animals are well described in the literature. In this review, the author offers a 3-step pathway of pathogenesis for syndactyly. The first step is initiated either by the overactivation of the WNT canonical pathway or the suppression of the Bone Morphogenetic Protein (BMP) canonical pathway. This leads to an overexpression of Fibroblast Growth Factor 8 (FGF8). The final step is the suppression of retinoic acid in the interdigital mesenchyme leading to suppression of both apoptosis and extracellular matrix (ECM) degradation, resulting in syndactyly.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31637260 PMCID: PMC6766129 DOI: 10.1155/2019/9652649
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1Human syndactyly and the 3-step pathway of pathogenesis.
Syndactyly in humans classified according to the steps shown in Figure 1.
| Step affected | Gene mutation | Name of syndrome or type of syndactyly as per Malik's classification (OMIM if available) |
|---|---|---|
| IA: activation of the WNT canonical signaling or the accumulation of beta catenin | (i) | (i) Cenani–Lenz syndrome or type 7a syndactyly (212780) |
| (ii) | (ii) Cenani–Lenz phenotype | |
|
| ||
| IB: suppression of the BMP canonical signaling | (i) | (i) Cenani–Lenz phenotype or type 7b syndactyly |
| (ii) | (ii) Haas (type 4) syndactyly (186200); triphalangeal thumb polysyndactyly syndrome (174500) | |
| (iii) | (iii) Carpenter syndrome (201000) | |
| (iv) | (iv) Saethre–Chotzen syndrome (101400) | |
| (v) | (v) Greig syndrome (175700) and other GLI3-related syndactyly | |
| (vi) | (vi) Johnston–Kirby type 3 syndactyly (186100) | |
|
| ||
| II: increased activity of FGF8 | (i) Gain-of-function mutations of | (i) Pfeiffer (101600), Apert (101200), and Saethre-Chotzen (101400) syndromes. |
| (ii) | (ii) Debeer type 2b syndactyly (608180) | |
|
| ||
| III: suppression of retinoic acid or suppression of apoptosis/matrix degradation | (i) | (i) Vordingborg type 2a syndactyly (186000) and syndactyly type 5 (186300) |
Syndactyly in animal models classified according to the steps shown in Figure 1.
| Step affected | Animal model of syndactyly |
|---|---|
| IA: activation of the WNT canonical signaling or the accumulation of beta catenin | Mice with |
|
| |
| IB: suppression of the BMP canonical signaling or the suppression of BMPs/SMADs | (i) Murine limb deformity (Ld) model ( |
| (ii) Transgenic chick with Grem1 overexpression | |
| (iii) Overexpression of the Bmp antagonist Noggin | |
| (iv) Inactivation of the Bmp receptor gene | |
| (v) Mice deficient in Bmp2 and Bmp4 | |
| (vi) Knockout mice lacking Cx43 | |
| (vii) Selective inactivation of Smad 1 and 5. | |
| (viii) Hammer toe (Hm) mutant mice. | |
|
| |
| II: overexpression of FGF8 | (i) Suppression of Notch signaling |
| (ii) | |
| (iii) Rounded foot mouse mutants ( | |
| (iv) Mice lacking Nidogen 1 and 2. | |
|
| |
| III: suppression of retinoic acid or suppression of apoptosis/extracellular matrix degradation | (i) Suppression of retinoic acid activity |
| (ii) Spdh/Spdh mice | |
| (iii) | |
| (iv) Mice deficient in ADAMTS | |
| (v) Knockout of | |
Other types of syndactyly with a unique pathway of pathogenesis or with an undetermined pathogenesis.
| Type of syndactyly | Animals or humans | Gene mutation/knockout | Proposed pathogenesis as per our literature review |
|---|---|---|---|
| Poland syndrome (OMIM 173800) | Humans | — | Unique pathway: vascular insult to the subclavian artery during the 19th embryonic stage |
| Shaker syndactyly | Mice |
| Fibrillin-Fibulin interactions leading to increased Fgf8 activity (step II) |
| Type 9 human syndactyly (OMIM 609432) and mice deficient in BhLha9 | Humans/mice | Loss-of-function mutations of | Either through suppression of Notch signaling (step II, see |
|
| Mice |
| The overexpression of Ihh in the interdigital spaces leading to reduced apoptosis (step III) |
|
| Mice |
| The mild deficiency in Fgf8 leads to overexpression of Fgf4 in the AER resulting in syndactyly |
| Type 8 human syndactyly (OMIM 309630) | Humans |
| Either via altering the expression of FGF8 or SHH |
AER: apical ectodermal ridge.